Dapagliflozin Audit DUK Professional Conference, Manchester, March 2017 - Poster

The effect of dapagliflozin on HbA1c and weight after its addition to commonly prescribed dual combination diabetes medication regimes in people with type 2 diabetes in a real-world UK setting: the ABCD nationwide dapagliflozin audit

M Yadagiri¹, P Sen Gupta¹, A.Kennedy², T Pang³, L Balamuri⁴, T Robinson⁵, S Bain⁶, IW Gallen⁷, K Adamson⁸, REJ Ryder¹, the ABCD nationwide dapagliflozin audit contributors⁹

¹Sandwell and West Birmingham Hospital NHS Trust, Birmingham

²Antrim Area Hospital, Antrim

³Dudley Group of Hospitals, Dudley

⁴Chorley and South Ribble Hospital, Lancashire

⁵Royal United Hospital, Bath

⁶Abertawe Bro Morgannwg University NHS Trust, Swansea

⁷Royal Berkshire NHS Trust, Reading

⁸West Lothian NHS Trust, Edinburgh

⁹Various hospitals and health centres, various towns, UK